In that year, Dr. Corneliu Giurgea, a Romanian scientist, synthesized piracetam for the first time. Piracetam is classified as a nootropic, although the term nootropic was not used until 1972. Dr. Giurgea coined the term “nootropic” by combining the Greek words for mind (nous) and bend (trepein). Nootropic literally translates into the phrase “mind bender.”
The use of cognition-enhancing drugs by healthy individuals in the absence of a medical indication spans numerous controversial issues, including the ethics and fairness of their use, concerns over adverse effects, and the diversion of prescription drugs for nonmedical uses, among others. Nonetheless, the international sales of cognition-enhancing supplements exceeded US$1 billion in 2015 when global demand for these compounds grew.